Related Experiment Video
Updated: May 23, 2026
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Intravaginal Aloe barbadensis and cervical HPV clearance: A retrospective observational study
Belma Gozde Ozdemir1, Fazil Avci1, Leyla Huseynli1
1Selcuk University Faculty of Medicine, Obstetrics and Gynecology Department, Konya, Turkey.
Background:
Persistent infection with human papillomavirus (HPV) is a key factor in cervical carcinogenesis. Immune-mediated mechanisms play a central role in viral clearance, leading to interest in immunomodulatory supportive therapies.
Objectives:
This study aimed to evaluate the association between intravaginal Aloe barbadensis use and HPV clearance in HPV-positive women.
Methods:
This retrospective observational study included 251 HPV-positive women aged ≥30 years. Of these, 164 received intravaginal Aloe barbadensis-containing vaginal capsules for 10 days, while 87 received no immunomodulatory treatment. HPV-PCR and cytological results were evaluated at baseline and after one year of follow-up.
Results:
HPV clearance was observed in 45.7% of patients in the Aloe barbadensis group and 36.8% in the control group, with no statistically significant difference between groups (p = 0.219). Subgroup analyses based on smoking status and HPV genotype also revealed no significant differences in clearance rates.
Conclusion:
Intravaginal Aloe barbadensis use was not associated with a statistically significant improvement in HPV clearance. The findings highlight the complexity of HPV persistence and suggest that single-agent immunomodulatory interventions may have limited clinical impact.
